Aurobindo Pharma reported INR180.39B in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Cipla INR 69.77B 366.6M Sep/2026
Divis Laboratories Ltd INR 20.43B 3.15B Mar/2026
Dr.Reddys Laboratories INR 154.3B 3.04B Sep/2026
Hindustan Unilever INR 192.95B 37.46B Sep/2026
Sun Pharmaceuticals INR 226.22B 7.93B Mar/2026
UPL INR 347.48B 16.58B Mar/2026